Cardiac Marker Testing Market Forecasted to Achieve Record Growth by 2034
Cardiac Marker Testing Market Forecasted to Achieve Record Growth by 2034
Blog Article
Market Overview
Global Cardiac Marker Testing Market size and share is currently valued at USD 4,804.49 million in 2024 and is anticipated to generate an estimated revenue of USD 11,771.28 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 9.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
The increasing global prevalence of lifestyle-related risk factors—such as hypertension, obesity, diabetes, and smoking—has resulted in a growing pool of individuals vulnerable to heart disease. Coupled with expanding access to healthcare and the rise of point-of-care diagnostics, this has significantly increased the utilization of cardiac marker tests in emergency rooms, ambulatory settings, and intensive care units.
Market Trends and Opportunities
Several evolving trends and emerging opportunities are shaping the future of the cardiac marker testing market:
- Technological Advancements in Point-of-Care Testing
The shift toward decentralized and rapid testing is driving demand for point-of-care cardiac marker testing devices that offer immediate results. These portable systems are particularly valuable in ambulances, rural clinics, and emergency departments, where time is critical in diagnosing heart attacks.
- Integration of High-Sensitivity Assays
High-sensitivity troponin assays (hs-cTn) are becoming the standard in early MI detection. These assays can detect even minute levels of cardiac troponins, enabling earlier and more accurate diagnosis of ACS. Their adoption is expanding rapidly in both developed and developing markets.
- Rising Incidence of Cardiovascular Diseases
According to the WHO, nearly 18 million people die each year from cardiovascular conditions, representing 32% of global deaths. This growing burden has led to a higher volume of cardiac testing in primary care, preventive screenings, and hospital admissions.
- Increasing Use of Multimarker Testing
To improve diagnostic accuracy and risk stratification, healthcare providers are increasingly relying on multimarker panels that include troponin, BNP/NT-proBNP, CRP, and CK-MB. These panels offer a more comprehensive picture of cardiac function and disease progression.
- Aging Population and Chronic Disease Monitoring
As the global geriatric population rises, so does the prevalence of chronic heart conditions. Cardiac marker testing is becoming essential not only for acute diagnosis but also for long-term management of patients with heart failure and ischemic heart disease.
- Telemedicine and At-Home Diagnostics
The integration of cardiac marker testing with telehealth and at-home monitoring platforms is an emerging opportunity. Advances in microfluidics, biosensors, and wearable technologies are enabling remote and continuous monitoring of cardiac health.
- Regulatory Approvals and R&D Funding
Regulatory bodies such as the U.S. FDA and European Medicines Agency are accelerating the approval of new biomarker assays, while governments and private investors are increasing R&D funding in cardiovascular diagnostics.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/cardiac-marker-testing-market
Segment Analysis
The cardiac marker testing market is segmented by Biomarker Type, Product, Testing Location, and End-user.
By Biomarker Type:
- Troponin I and T: The most specific and sensitive markers for myocardial infarction; dominate the market.
- CK-MB: Still used in some settings, especially in conjunction with troponin for confirmatory testing.
- Myoglobin: Offers early detection but lacks specificity.
- BNP and NT-proBNP: Widely used for diagnosing and monitoring heart failure.
- C-Reactive Protein (CRP): Used as an inflammatory marker, often in risk assessment for cardiovascular events.
Troponin remains the largest biomarker segment, due to its clinical importance in MI diagnosis and the growing availability of high-sensitivity assays.
By Product:
- Reagents and Kits: Includes assay kits for use with laboratory or POC analyzers; represent the largest share.
- Instruments and Analyzers: Includes bench-top and portable analyzers used in diagnostic labs, hospitals, and ambulances.
The reagents and kits segment is expected to continue dominating due to the recurring need for testing and the growing volume of cardiac diagnostics.
By Testing Location:
- Laboratory Testing: Conducted in centralized hospital or reference laboratories; offers higher throughput and accuracy.
- Point-of-Care Testing (POCT): Rapid testing at or near the patient; expanding rapidly due to convenience and shorter turnaround times.
POCT is the fastest-growing segment, particularly in emergency and rural healthcare settings, owing to its ability to support early intervention.
By End-user:
- Hospitals and Clinics
- Diagnostic Laboratories
- Ambulatory Care Centers
- Research and Academic Institutes
- Home Healthcare Settings
Hospitals hold the largest market share, driven by high patient volumes and the need for critical diagnostics. However, ambulatory care and home healthcare settings are expected to grow significantly due to the expansion of outpatient and remote care.
Regional Analysis
North America
North America remains the largest market, led by the U.S., due to advanced healthcare systems, high awareness, and strong adoption of point-of-care testing. The region’s high prevalence of heart disease and supportive reimbursement policies drive growth.
Europe
Europe is a major market with strong demand for high-sensitivity assays and multimarker testing. Countries such as Germany, the UK, and France are investing in preventive cardiology and early diagnosis initiatives.
Asia-Pacific
Asia-Pacific is the fastest-growing region, fueled by rising healthcare investments, growing middle-class populations, and increasing prevalence of CVDs in countries like China, India, and Japan.
Latin America and Middle East & Africa
These regions are emerging markets with increasing access to healthcare services and government-led programs for cardiovascular screening and prevention. Economic development and awareness campaigns are expected to enhance market penetration.
Key Companies
Several prominent companies are leading the cardiac marker testing market by introducing novel products, securing regulatory approvals, and expanding their global footprint. These firms focus on delivering innovative diagnostic solutions that improve the speed and accuracy of cardiac event detection.
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- CardioGenics Holdings Inc.
- Danaher Corporation
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd.
- LSI Medience Corporation
- Ortho Clinical Diagnostics
- PerkinElmer Inc.
- Quidel Corporation
- Randox Laboratories Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Conclusion
The Cardiac Marker Testing Market is entering a dynamic growth phase, propelled by rising cardiovascular health challenges and an increasing focus on timely diagnosis and intervention. With the rapid development of point-of-care technologies, high-sensitivity assays, and remote diagnostics, cardiac marker testing is becoming faster, more accessible, and more impactful than ever before.
As healthcare systems worldwide seek to improve outcomes and reduce the burden of CVDs, cardiac marker testing will remain a cornerstone of diagnostic strategy—delivering accurate, actionable insights that save lives.
More Trending Latest Reports By Polaris Market Research:
Jars Market
North America SGLT2 Inhibitors Market
Linear LED Strip Fixture Market
Green Ammonia Market
U.S. Sterilization Services Market
Specialty Polyamides Market
Saudi Arabia Halal Cosmetics Market
Saudi Arabia Halal Cosmetics Market
Green Ammonia Market
LNG Storage Tanks Market
CNG Tanks Market
Facades Market
Automatic Content Recognition Market
Industrial Boiler Market
Specialty Polyamides Market
Brugada Syndrome Market
Brugada Syndrome Market
Automatic Content Recognition Market Report this page